ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166641 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166641; 2) Community: the network communities that were significantly associated with the response to NSC 166641; 3) Molecule: the relationships between components within communities and NSC 166641; 4) MDR: the compounds that were significantly associated with the NSC 166641.

NSC Compound Enrichment Correlation
NSC 699490 Doxoform 4.91939766674006e-005 0.54967396
NSC 740276 5,6-Dihydro-6-[3-(hydroxyethyl)amino-1-propyl]-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloide 5.49145982993956e-005 0.5335829
NSC 132313 Dianhydrogalactitol 5.88106018705558e-006 0.59960388
NSC 680418 Null 6.10737882231374e-006 0.31855586
NSC 697189 Null 7.15924811036872e-008 0.46757059
NSC 683247 Acridine-4-carboxamide, 9-amino-5-methyl- N-[2-(dimethylamino)ethyl]-, dihydrochloride 8.12512419150683e-005 0.43886414
NSC 154318 Methanesulfon-m-anisidide, 4'-[(3-chloro-5-methoxy-9-acridinyl)amino]-, monomethanesulfonate 9.15580043872282e-005 0.52716336
NSC 639174 Camptothecin Derivative 9.15580043872288e-005 0.48633077
NSC 659162 1H-Benzimidazole, 5,5'-dithiobis[2-(trifluoromethyl)- (9CI) 9.15580043872288e-005 0.23883949
NSC 742799 3-amino-N-(4-benzylphenyl)-1H-indazole-1-carboxamide 9.15580043872288e-005 0.32327299
Total:106  Current:105    [First] [Prev] [Next] [Last]